<bill session="118" type="s" number="1250" updated="2025-11-19T02:34:51Z">
  <state datetime="2023-04-20">REFERRED</state>
  <status>
    <introduced datetime="2023-04-20"/>
  </status>
  <introduced datetime="2023-04-20"/>
  <titles>
    <title type="display">Drug-price Transparency for Consumers Act of 2023</title>
    <title type="short" as="introduced">Drug-price Transparency for Consumers Act of 2023</title>
    <title type="official" as="introduced">A bill to amend title XI of the Social Security Act to require that direct-to-consumer advertisements for drugs and biologicals include an appropriate disclosure of pricing information.</title>
  </titles>
  <sponsor bioguide_id="D000563"/>
  <cosponsors>
    <cosponsor bioguide_id="B001230" joined="2023-04-20"/>
    <cosponsor bioguide_id="B001277" joined="2023-04-20"/>
    <cosponsor bioguide_id="B001310" joined="2023-04-20"/>
    <cosponsor bioguide_id="B000944" joined="2023-07-12"/>
    <cosponsor bioguide_id="G000386" joined="2023-04-20"/>
    <cosponsor bioguide_id="K000383" joined="2023-04-20"/>
    <cosponsor bioguide_id="S001203" joined="2023-09-07"/>
    <cosponsor bioguide_id="V000137" joined="2023-04-20"/>
  </cosponsors>
  <actions>
    <action datetime="2023-04-20">
      <text>Introduced in Senate</text>
    </action>
    <action datetime="2023-04-20" state="REFERRED">
      <text>Read twice and referred to the Committee on Finance.</text>
      <reference ref="CR S1297" label="Sponsor introductory remarks on measure"/>
      <reference ref="CR S1297-1298" label="text"/>
    </action>
  </actions>
  <committees>
    <committee code="SSFI" name="Senate Finance" subcommittee="" activity="Referred To"/>
  </committees>
  <relatedbills>
    <bill session="118" type="h" number="5958" relation="identical"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
    <term name="Administrative law and regulatory procedures"/>
    <term name="Civil actions and liability"/>
    <term name="Department of Health and Human Services"/>
    <term name="Health care costs and insurance"/>
    <term name="Marketing and advertising"/>
    <term name="Prescription drugs"/>
  </subjects>
  <amendments/>
  <summary date="2024-03-27T14:55:23Z" status="Introduced in Senate">Drug-price Transparency for Consumers Act of 2023 or the DTC Act of 2023 This bill requires consumer advertisements for drugs and biologicals to include certain price information if the drug or biological is (1) covered under Medicare or Medicaid, and (2) required to include a risk summary under current law. The requirement does not apply to advertisements for drugs or biologicals with a wholesale cost of less than $35 for a one-month supply. Each violation of this requirement is subject to a civil penalty of not more than $100,000.</summary>
</bill>
